Hadassah

Hadassah Physicians’ Study Supports Novel Needle for Spinal Fluid Sampling

Thursday, Mar 15 2012

A Hadassah University Medical Center study, which demonstrated the benefits of using a novel needle for spinal fluid sampling, was highlighted in the December 2011 issue of the British Journal of Anesthesia.

The article, authored by Dr. Yehuda Ginosar of the Department of Anesthesiology and Critical Care Medicine and Prof. Tamir Ben-Hur, head of Hadassah's Department of Neurology, along with Dr. Yoav Smith of the Genomic Data Analysis Unit at the Hadassah-Hebrew University Medical School, and American Student Jordana Lovett, supports the use of a 22 G spinal needle with a tapered 27 G pencil-point tip for spinal fluid extraction. Traditionally, the authors note, "parallel-walled spinal needles ≤22 G are used for lumbar punctures, despite a reported greater than 32 percent incidence of post-dural puncture headache." The researchers had hypothesized that despite the smaller puncture hole with their tapered spinal needle, the needle would have similar cerebrospinal fluid pressure equilibration times. The researchers concluded that "a 22/27 G tapered spinal needle has similar flow properties to the 22 G needle, despite a 27 G tip."

Ms. Lovett is the granddaughter of Hadassah supporters Alma and Burt Krull of the Brooklyn Region of Hadassah. She is now working toward her PhD in molecular biology at the City University of New York. Click here to read the abstract in the British Journal of Anesthesia.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More